The lack of focus on Hormone Replacement Therapy (HRT) medication is highlighted due to male-dominated executive leadership in the companies that produce it. The shortage of HRT medication is discussed in comparison to other global shortages. The author shares their personal experience with menopause and the positive impact of HRT. The fear factor associated with HRT is diminishing with safer options available. The author calls for increased production of HRT patches to meet the demand, pointing out the lack of gender balance in the leadership of the pharmaceutical manufacturer. The importance of women’s health and the necessity of consistent access to HRT is emphasized.
Source link